A Flexible Workflow for Automated Bioluminescent Kinase Selectivity Profiling

Tracy Worzella1, Matt Butzler1, Jacquelyn Hennek1,2

  • 11 Promega Corporation, R&D Department, Madison, WI, USA.

SLAS Technology
|January 18, 2017
PubMed
Summary

This study presents an automated kinase profiling workflow for drug discovery, enabling researchers to efficiently assess inhibitor selectivity and off-target activities in-house. The streamlined process confirms known interactions and identifies novel ones, accelerating compound evaluation.

Related Concept Videos